ESSEX INVESTMENT MANAGEMENT CO LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 221 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,733,000
+19.9%
102,223
+0.5%
0.20%
+12.7%
Q2 2018$1,445,000
+209.4%
101,763
+231.6%
0.18%
+166.2%
Q4 2014$467,000
+86.1%
30,684
+32.0%
0.07%
+78.9%
Q3 2014$251,00023,2370.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders